$25.24
-0.30 (-1.17%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+101.60%
YTD
+8.37%
Open$25.74
Previous Close$25.54
Day High$25.74
Day Low$25.02
52W High$31.74
52W Low$11.68
Volume—
Avg Volume1.92M
Market Cap3.25B
P/E Ratio—
EPS$-3.90
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$22.13
Above
SMA 200
$15.14
Above
RSI (14)
36.6
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
19 analysts
Price Target
+298.2% upside
Current
$25.24
$25.24
Target
$100.50
$100.50
$77.00
$100.50 avg
$121.27
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 304.15M | 233.68M | 841.86M |
| Net Income | -434,688,215 | -300,568,065 | -67,570,170 |
| Profit Margin | -142.9% | -135.8% | -8.0% |
| EBITDA | -463,003,521 | -337,932,809 | -58,220,570 |
| Free Cash Flow | — | — | -41,442,789 |
| Rev Growth | +30.2% | +30.2% | +8.2% |
| Debt/Equity | 0.16 | 0.16 | 0.24 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $264.48 | +0.20% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $393.16 | +1.95% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $150.56 | +0.30% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $510.72 | +0.47% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $798.17 | +1.70% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $244.32 | +1.99% | 40.0 | 32.33B |